Viewing Study NCT02393794


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-03-05 @ 3:42 PM
Study NCT ID: NCT02393794
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-06
First Post: 2015-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
Sponsor: Priyanka Sharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module